The company has legally retrieved all intellectual data related to stage 2 clinical trial data, along with all previous data from Hemostemix Israel and the randomized table needed to evaluate ACP-01 clinical trial data in North America and South Africa.
Universal Ibogaine Inc. (UI) (TSXV: IBO) (OTC: IBOGF) hottest stock making heavy profit. Click below link to know more
so keep Update your ideas with the new addition of $IBO Update your watch list with the new addition of $IBO Stocks veered from bearish to bullish day by day & leaving investors amazed in the Tsx_v market
Universal Ibogaine Inc. is a life science company listed on OTC with the ticker symbol $IBOGF, currently sits at $0.0341 with the average market volume of 5k+
Dr. Alberto Sola, the co-founder of $IBOGF is going to present his latest findings in a panel titled “Ibogaine Hydrochloride and Acute Opioid Detox”.